2038-32-6

Basic information

• Product Name: 4-Pyrimidinamine, 6-(methylthio)- (9CI)
• Synonyms: 4-Pyrimidinamine, 6-(methylthio)- (9CI);[6-(methylthio)pyrimidin-4-yl]amine;6-methylsulfanylpyrimidin-4-amine
• CAS NO: 2038-32-6
• Molecular Formula: C₅H₇N₃S
• Molecular Weight: 141.19418
• Product Categories: PYRIMIDINE
• Mol File: 2038-32-6.mol
• Article Data: 1

Chemical Properties

• Boiling Point: 318.9°Cat760mmHg
• Flash Point: 146.7°C
• Appearance: /
• Density: 1.28g/cm³
• Vapor Pressure: 0.000351mmHg at 25°C
• Refractive Index: 1.623
• CAS DataBase Reference: 4-Pyrimidinamine, 6-(methylthio)- (9CI)(CAS DataBase Reference)
• NIST Chemistry Reference: 4-Pyrimidinamine, 6-(methylthio)- (9CI)(2038-32-6)
• EPA Substance Registry System: 4-Pyrimidinamine, 6-(methylthio)- (9CI)(2038-32-6)

Safety Data

• Hazardous Substances Data: 2038-32-6(Hazardous Substances Data)

Usage

InChI:InChI=1/C5H7N3S/c1-9-5-2-4(6)7-3-8-5/h2-3H,1H3,(H2,6,7,8)

Relevant articles and documents

Compounds for treating spinal muscular atrophy

Provided herein are compounds, compositions thereof and uses therewith for treating spinal muscular atrophy. In a specific embodiment, provided herein are compounds of a form that may be used to modulate the inclusion of exon 7 of SMN2 into mRNA that is transcribed from the SMN2 gene. In another specific embodiment, provided herein are compounds of a form that may be used to modulate the inclusion of exon 7 of SMN1 into mRNA that is transcribed from the SMN1 gene. In yet another embodiment, provided herein are compounds of a form that may be used to modulate the inclusion of exon 7 of SMN1 and SMN2 into mRNA that is transcribed from the SMN1 and SMN2 genes, respectively.